Christopher J. Michejda
23Patents
6h-index
29Co-inventors
69Inventor score
Filing activity: Mar 28, 1988 → Aug 18, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7105488B1 | G protein-coupled receptor antagonists | Physics | 18 | Expired |
| US5190969A | 2,3-epoxy derivatives as anti retrovital chemotherapeutic agents | Human Necessities | 13 | Expired |
| US6894068B2 | Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase | Chemistry; Metallurgy | 9 | Expired |
| US6187775A | Acridone-derived compounds useful as antineoplastic and antiretroviral agents | Human Necessities | 8 | Expired |
| US6369235B1 | Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection | Chemistry; Metallurgy | 7 | Expired |
| US6541483B2 | Acridone-derived compounds useful as antineoplastic and antiretroviral agents | Human Necessities | 7 | Expired |
| US6664263B2 | 1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity | Human Necessities | 4 | Expired |
| US4923970A | Substituted 1-(2-chloroethyl)-3-acyl-3-alkyltriazenes | Chemistry; Metallurgy | 4 | Expired |
| US7504430B2 | Maleiimide anti-tumor phosphatase inhibitors | Human Necessities | 4 | Active |
| US5508289A | Bis-acridone chemotherapeutic derivatives | Chemistry; Metallurgy | 4 | Expired |
| US6153589A | 2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents | Human Necessities | 4 | Expired |
| US5672593A | Bistriazenes as chemotherapeutic agents | Chemistry; Metallurgy | 4 | Expired |
| US7605125B2 | DNA-binding polyamide drug conjugates | Human Necessities | 1 | Expired |
| US7517849B1 | Inhibition of ABC transporters by transmembrane domain analogs | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5808038A | Bistriazenes as chemotherapeutic agents | Chemistry; Metallurgy | 0 | Expired |
| US5731301A | Bistriazenes as chemotherapeutic agents | Chemistry; Metallurgy | 0 | Expired |
| US8008316B2 | Azonafide derived tumor and cancer targeting compounds | Chemistry; Metallurgy | 0 | Active |
| US9540427B2 | Peptide-based stat inhibitor | Human Necessities | 0 | Active |
| US8912146B2 | Derivatives of APF and methods of use | Human Necessities | 0 | Active |
| US9079936B2 | Derivatives of APF and methods of use | Human Necessities | 0 | Active |
| US9085604B2 | Antiproliferative factor and methods of use | Human Necessities | 0 | Active |
| US9326950B2 | Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs | Human Necessities | 0 | Active |
| US8680056B2 | Antiproliferative factor and methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.